In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism - Université Paris-Est-Créteil-Val-de-Marne Access content directly
Journal Articles Antimicrobial Agents and Chemotherapy Year : 2019

In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism

A. Bidaud
  • Function : Author
F. Botterel
A. Chowdhary

Abstract

Candida auris is an emerging, multidrug-resistant pathogen responsible for invasive hospital-acquired infections. Flucytosine is an effective anti- Candida species drug, but which cannot be used as a monotherapy because of the risk of development of resistant mutants during treatment. It is, therefore, noteworthy to test possible combinations with flucytosine that may have a synergistic interaction.

Dates and versions

hal-03997625 , version 1 (20-02-2023)

Identifiers

Cite

A. Bidaud, F. Botterel, A. Chowdhary, E. Dannaoui. In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism. Antimicrobial Agents and Chemotherapy, 2019, 63 (12), ⟨10.1128/AAC.01393-19⟩. ⟨hal-03997625⟩
34 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More